JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

Bromodomain

B1498 I-BET-762
4 Citation

Target: Bromodomains

Summary: BET inhibitor,highly potent

≥21.19 mg/mL
B1081 CPI-203
1 Citation

Summary: BET bromodomain inhibitor

≥40 mg/mL
B1013 GSK1324726A

Target: Bromodomains

Summary: BET proteins inhibitor
B1012 MS436

Target: Bromodomains

Summary: BRD4 inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.15 mg/mL
A8810 UNC669

Summary: L3MBTL antagonist,potent and selective
A8181 (-)-JQ1
16 Citation

Target: Bromodomains

Summary: Stereoisomer of (+)-JQ1, used as negative control

≥22.85 mg/mL
A4491 SGC-CBP30
2 Citation

Target: CREBBP|EP300

Summary: Inhibitor of CREBBP/EP300 bromodomain,potent

≥20.05 mg/mL
A4490 I-CBP 112

Target: CREBBP|EP300

Summary: CBP/EP300 bromodomain inhibitor

≥49.6 mg/mL
A4186 Bromosporine
1 Citation

Target: Bromodomains

Summary: Bromodomain inhibitor,non-selective

≥40.4 mg/mL
A4184 PFI-1 (PF-6405761)
1 Citation

Target: Bromodomains

Summary: BET inhibitor

insoluble in H2O; insoluble in EtOH; ≥128.4 mg/mL